Nasal allergen challenge studies of allergic rhinitis: a guide for the practicing clinician
Annals of Allergy, Asthma & Immunology
September 2014 Volume 113, Issue 3, Pages 250-256
Participants will be able to demonstrate increased knowledge of the clinical treatment of allergy/asthma/immunology and how new information can be applied to their own practices.
Accreditation: The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation: The American College of Allergy, Asthma&Immunology (ACAAI) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Planning Committee Members:
Anne K. Ellis, MD, MSc, FRCPC (Author)
Mitchell H. Grayson, MD (CME Series Editor, Deputy Editor)
Gailen D. Marshall, Jr., MD, PhD (Editor-in-Chief)
Physicians involved in providing patient care in the field of allergy/asthma/immunology
At the conclusion of this activity, participants should be able to:
- Describe nasal allergen challenge (NAC) methodology
- Discuss how the NAC study designs, objective measures and biological sampling techniques inform studies of the pathophysiology of allergic rhinitis and clinical efficacy of novel therapies for allergic rhinitis
Mena Soliman, MB ChB; Michelle L. North, PhD; Lisa M. Steacy, BSc; Jenny Thiele, MSc; Daniel E. Adams, BSc; and Anne K. Ellis, MD, MSc, FRCPC
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance